Biomarkers and Choroidal Neovascularization
The aim of the study is to find biomarkers in the blood and aqueous humor of patients with type 1 choroidal neovascularization and correlate them with the response to anti-VEGF treatment.
Patients with type 1 choroidal neovascularization in a context of central serous... [+5]
Myocardial infarction < 12 months [+7]